morbid obesity

31
Morbid Obesity By Prof Dr WALEED IBRAHIM

Upload: finnea

Post on 22-Mar-2016

45 views

Category:

Documents


0 download

DESCRIPTION

Morbid Obesity. By Prof Dr WALEED IBRAHIM. Definition . O besity has been defined as excess body fat relative to lean body mass. The most widely accepted measure of obesity is the body mass index (BMI). BMI= Patient’s weight in kg / square of patient’s height in meters (kg/m²). - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: Morbid Obesity

Morbid ObesityBy Prof Dr

WALEED IBRAHIM

Page 2: Morbid Obesity

Obesity has been defined as excess body fat relative to lean body mass.

The most widely accepted measure of obesity is the body mass index (BMI).

BMI= Patient’s weight in kg / square of patient’s height in meters (kg/m²).

A normal BMI ranges from 18.5 to 24.9 kg/m²

Definition

Page 3: Morbid Obesity

BMI 25-29.9 = overweight. BMI ≥30 = obesity. BMI ≥35 = severe obesity. BMI ≥40 = morbid obesity. BMI ≥45 = super obese.

Classification

Page 4: Morbid Obesity

GENETIC ( rare )

A. SYNDROMES INDUCING OBESITY: Prader- Willi : Hypotonia, Hyperphagia, M R, Facial

features Laurence- Moon : Ret. Pig, M R , Sp. Pplegia,

Hypogonad Bardet-Biedl : Polydactyly, Renal failure

B. CHROMOSOMAL DEFECTS:

AETIOLOGY OF OBESITY

Page 5: Morbid Obesity

NUTRITIONAL : Intra-uterine, Infancy, Dietary.

PHYSICAL INACTIVITY : TV., Internet, Lifestyle, Technology.

TRAUMA :NEUROLOGICAL : Post op., Head injuries.PSYCHOLOGICAL : Stresses, Abuse….

MEDICATIONS : Steroids, Psychotropic drugs.

SOCIAL : Economic, Ethnic.

ENVIRONMENTAL

Page 6: Morbid Obesity

HYPOTHALAMIC-PITUITARY GONADAL : Polycystic Ovary ADRENAL : Cushing THYROID PANCREATIC : Hyperinsulinaemia

NEURO-ENDOCRINE

Page 7: Morbid Obesity

COMBINATION OF : OBESITY ( Esp. CENTRAL ) + 2 of : HT. DM. DYSLIPIDEMIA

METABOLIC SYNDROME

Page 8: Morbid Obesity

The American Heart Association and the National Heart, Lung, and Blood Institute recommend that the metabolic syndrome be identified as the presence of three or more of:

Elevated waist circumference:Men —Equal to or greater than 40 inches (102 cm)Women — Equal to or greater than 35 inches (88 cm)

Elevated triglycerides:Equal to or greater than 150 mg/dL

AHA

Page 9: Morbid Obesity

Reduced HDL (“good”) cholesterol:Men — Less than 40 mg/dLWomen — Less than 50 mg/dL

Elevated blood pressure:Equal to or greater than 130/85 mm Hg

FBS equal or greater than 100mg/dL

Page 10: Morbid Obesity

Morbidly obese patients are classified according to area of main fat mass:

Peripheral (Gynecoid) obesity: associated with degenerative joint disease and venous stasis in the lower extremities.

Central (Android) obesity: associated with the highest risk of mortality related problems due to the “Metabolic Syndrome” as well as increased intra-abdominal pressure.

Complications of obesity

Page 11: Morbid Obesity

Management of obesity

Page 12: Morbid Obesity

1. Dietary therapy2. Physical activity therapy3. Drug therapy4. Behavioural therapy

Non surgical treatment

Page 13: Morbid Obesity

Candidates for surgery1) BMI ≤ 40 Kg/m² or ≤ 35 Kg/m² with

significant cormobidities.2) Failure of non surgical weight loss

programs.3) Capability of tolerating surgery.4) Absence of endocrine disorders that can

cause massive obesity.5) Psychological stability with supportive

social environment.

Surgical management

Page 14: Morbid Obesity

6) Age less than 60 years7) Basic understanding of how obesity

surgery causes weight loss.8) Realization that surgery itself does not

guarantee weight loss9) Absence of active alcohol and drug abuse.10) Commitment to post-operative follow up.

Page 15: Morbid Obesity

1- Restrictive procedures:A)Vertical banded gastroplasty (VBG)

Bariatric Surgical Procedures

Page 16: Morbid Obesity

B) Adjustable gastric banding (AGB)

Page 17: Morbid Obesity

C) Sleeve Gastrectomy (SG)

Page 18: Morbid Obesity

2- Malabsorptive procedures :A) Roux en Y Gastric bypass(RYGBP)

Page 19: Morbid Obesity

B) Minigastric bypass

Page 20: Morbid Obesity

The aim of bariatric surgery is to induce weight loss that is sufficient to reduce obesity-related morbidities to acceptable levels.

Loss of visceral fat is associated with improved insulin sensitivity and glucose metabolism , also reduces intra-abdominal pressure and this change may result in improvement in urinary incontinence, gastroesophageal reflux, systemic hypertension, venous stasis disease, and hypoventilation.

Outcome of Bariatric Surgery

Page 21: Morbid Obesity

70-80% IMROVEMENT OF CO-MORBIDITIES :

- TYPE 2 DM. - HYPERTESION. - DYSLIPIDAEMIA.- HYPERURICAEMIA.- SLEEP APNOEA.- CARDIAC RISK.- CANCER RISK.- GERD.- PCOS.

Page 22: Morbid Obesity

QUALITY OF LIFE:- SOCIAL.- WORK.- SEXUAL.- PSYCHOLOGICAL

IT WAS FOUND THAT THESE POSITIVE CHANGES START (& PERSIST) AS EARLY AS WHEN 10% EWL OCCURS.

Page 23: Morbid Obesity
Page 24: Morbid Obesity

1 st, 3 rd,6 th, 12 th MONTH POSTOPERATIVELY, THEN ANNUALLY.

DO NOT FORGET:-ELECTROLYTES.-B. SUGAR.-RENAL FUNCTIONS.-LIVER FUNCTIONS.-TRANSFERRIN.- LIPID PROFILE.

FOLLOW UP

Page 25: Morbid Obesity

OUR EXPERIENCE

Page 26: Morbid Obesity
Page 27: Morbid Obesity
Page 28: Morbid Obesity
Page 29: Morbid Obesity
Page 30: Morbid Obesity
Page 31: Morbid Obesity

THANK YOU